Living evidence base for Cochrane Review "Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19"

We maintain this Excel spreadsheet on OSF to improve transparency between published updates of the Living Systematic Review "Nirmatrelvir combined with ritonavir for preventing and treating COVID-19" (trade name: Paxlovid) [available at: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015395.pub3/full]. It details the bi-monthly search and surveillance process, enabling the review´s readers to track the progress of eligible studies, whether completed or ongoing. Methods publication: "Pragmatic and open science-based solution to a current problem in the reporting of living systematic reviews [available at: http://dx.doi.org/10.1136/bmjebm-2022-112019]

本数据集以 Excel 电子表格形式存储于 OSF 平台，旨在增强《尼马特韦联合利托那韦预防及治疗 COVID-19 的系统性综述》（商品名：Paxlovid，详见：https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015395.pub3/full）的发布更新透明度。该表格详述了每两个月进行的搜索与监控过程，使综述的读者能够追踪合格研究的进展，无论是已完成还是正在进行中的研究。方法学出版物：《针对现有系统性综述报告问题的一种实用且基于开放科学的解决方案》（详见：http://dx.doi.org/10.1136/bmjebm-2022-112019）